Reference : Actualites therapeutiques en neuropediatrie
Scientific journals : Article
Human health sciences : Neurology
Human health sciences : Pediatrics
http://hdl.handle.net/2268/71356
Actualites therapeutiques en neuropediatrie
French
[en] Update in drug therapy in neuropediatry
Leroy, Patricia [Université de Liège - ULG > pédiatrie > > >]
Dubru, Jean-Marie [Université de Liège - ULg > > Pédiatrie - Pédiatrie CHR >]
Misson, Jean-Paul mailto [Université de Liège - ULg > Département des sciences cliniques > Pédiatrie >]
2007
Revue Médicale de Liège
62
5-6, May-Jun
449-450
Yes (verified by ORBi)
National
0370-629X
[fr] traitement antiépileptic ; enfant ; methylphénidate ; atomoxetine ; troubles de l'attention et hyperactivité
[en] The most recent antiepileptic drugs used in children are lamotrigine, topiramate, oxcarbamaz6pine and levetiracetam. Their efficacy is proven, depending on the type of crisis, but in Belgium they are reimbursed only in certain conditions. The treatment of children with attention deficit hyperactivity disorder (ADHD), which was only constituted of methylphenidate, can now benefit from atomoxetine whose mechanism of action is different.
Professionals ; Students
http://hdl.handle.net/2268/71356
http://www.rmlg.ulg.ac.be/

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
23n.pdfPublisher postprint331.01 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.